|
|
|
|
|
|
Sponsors and Collaborators: |
Anbics Management-Services Ag Swiss National Science Foundation |
Information provided by: | Anbics Management-Services Ag |
ClinicalTrials.gov Identifier: | NCT00610623 |
The purpose of this study is to assess the clinical efficacy of azithromycin, used as a quorum-sensing blocker, when compared to placebo for preventing or delaying the occurrence of pneumonia in ventilated patients colonized with Pseudomonas aeruginosa.
Condition | Intervention | Phase |
Pneumonia, Ventilator-Associated Pseudomonas Infections |
Drug: azithromycin Drug: placebo |
Phase II |
MedlinePlus related topics: | Pneumonia |
ChemIDplus related topics: | Azithromycin |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Parallel Assignment, Safety/Efficacy Study |
Official Title: | Proof of Concept Study to Investigate the Impact of Azithromycin Administered iv Versus Placebo on the Prevention of Pneumonia in Ventilated Patients Colonized by Pseudomonas Aeruginosa |
Enrollment: | 92 |
Study Start Date: | April 2003 |
Study Completion Date: | October 2005 |
Primary Completion Date: | October 2005 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
1: Experimental
azithromycin iv 300 mg/day
|
Drug: azithromycin
300 mg/day, IV from day 1 to 20
|
2: Placebo Comparator
Placebo
|
Drug: placebo
once per day, IV from day 1 to 20
|
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Belgium | |||||
General Intensive Car Unit, Centre Hospitalier Universitaire de Liège | |||||
Liège, Belgium, B-4000 | |||||
Belgium, Louvain | |||||
Intensive Care Unit, Clinique Saint-Pierre | |||||
Ottignies, Louvain, Belgium, 1340 | |||||
France | |||||
Intensive Care Unit, Jean Minjoz University Hospital | |||||
Besancon, France, 25030 | |||||
Intensive Car Unit, Calmette University Hospital of Lille | |||||
Lille, France, 59037 | |||||
Medical-surgical intensive car unit, Dupuytren Teaching Hospital | |||||
Limoges, France, 8700 | |||||
Medical Intensive Car Unit, Hospital Bichat | |||||
Paris, France, 75018 | |||||
Surgical Intensive Car Unit; University Hospital Bichat | |||||
Paris, France, 75018 | |||||
General Intensive Care Unit, Hospital Saint-Joseph | |||||
Paris, France, 75674 | |||||
Medical Intensive Care Unit, Cochin Hospital | |||||
Paris, France, 75679 | |||||
General Intensive Care Unit, Montauban City Hospital | |||||
Montauban, France, 82013 | |||||
Poland | |||||
Intensive Care Unit, Wojewodzki Hospital | |||||
Sosnowiec, Poland | |||||
Intensive Care Unit, Central Hospital | |||||
Warsaw, Poland | |||||
Intensive Care Unit, Wojewodzki Hospital | |||||
Krakow, Poland | |||||
Serbia and Montenegro | |||||
Surgical Intensive Care Unit, Clinical Center of Serbia | |||||
Belgrade, Serbia and Montenegro | |||||
Surgical Intensive Care Unit, Clinical Center of Serbia, Institut of Neurosurgery | |||||
Belgrade, Serbia and Montenegro | |||||
Spain | |||||
Intensive Care Unit, San Dureta University Hospital | |||||
Palma de Mallorca, Spain, 07014 | |||||
Intensive Care Unit, Hospital del Mar | |||||
Barcelona, Spain, 08003 | |||||
Internal Medicine, Vall d'Hebron Hospital | |||||
Barcelona, Spain, 08035 | |||||
Intensive Care Unit, Joan XXIII University Hospital | |||||
Tarragona, Spain, 43007 | |||||
Switzerland, Vaud | |||||
Surgical and Medical Intensive Care Units, University Hospital Lausanne | |||||
Lausanne, Vaud, Switzerland |
Anbics Management-Services Ag |
Swiss National Science Foundation |
Principal Investigator: | Christian Van Delden, MD | Service of Infectious Diseases, University Hospital Geneva, Switzerland |
Study Chair: | Jean Carlet, MD | General Intensive Care Unit, Hospital Saint-Joseph, Paris, France |
Responsible Party: | Service of Infectious Diseases, University Hospital Geneva ( Christian van Delden ) |
Study ID Numbers: | Anb006#2001 |
First Received: | January 24, 2008 |
Last Updated: | January 28, 2008 |
ClinicalTrials.gov Identifier: | NCT00610623 |
Health Authority: | Switzerland: Swissmedic |
|
|
|
|